This document summarises the evidence base on antimicrobial stewardship: prescribing antibiotics . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .
Summary of the evidence on remsima (infliximab biosimilar) for subcutaneous injection for managing rheumatoid arthritis
Summary of the evidence on fluticasone furoate, umeclidinium and vilanterol (Trelegy) for chronic obstructive pulmonary disease (COPD) to inform local NHS
Summary of the evidence on buprenorphine prolonged-release subcutaneous injection (Buvidal) for opioid dependence to inform local NHS
Summary of the evidence on doxylamine/pyridoxine (Xonvea) for treating nausea and vomiting of pregnancy in women aged 18 years and older to inform local NHS
Summary of the evidence on antimicrobial prescribing of meropenem with vaborbactam (Vaborem) to inform local NHS planning and decision making
Summary of the evidence on the antimicrobial prescribing of ceftolozane with tazobactam for hospital-acquired pneumonia, including ventilator-associated
Summary of the evidence on beclometasone, formoterol and glycopyrronium (Trimbow) for chronic obstructive pulmonary disease (COPD) to inform local NHS planning
Summary of the evidence on antimicrobial prescribing: cefiderocol
Summary of the evidence on antimicrobial prescribing: imipenem with cilastatin and relebactam
ES34 Product overview The content of this evidence summary was up to date in January 2021. See summaries of product characteristics
Summary of the evidence on antimicrobial prescribing: delafloxacin
ES24 . Key messages The content of this evidence review was up-to-date
ES25 . Key messages The content of this evidence review was up-to-date on 20 April 2020. See summaries of product characteristics
ES26 . Key messages The content of this evidence review was up-to-date on 13 May 2020. See summaries of product characteristics
ES23 . Key messages The content of this evidence review was up-to-date
ES27 . Key messages The content of this evidence review was up-to-date on 4 June 2020. See summaries of product characteristics
ES33 Product overview The content of this evidence summary was up to date in January 2021. See summaries of product characteristics
The percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with a beta-blocker licensed for heart failure.
The percentage of adults and young people at a GP surgery in an area of high or extremely high HIV prevalence who have not had an HIV test in the last
The percentage of patients aged 50 or over and who have not attained the age of 75, with a record of a fragility fracture on or after 1 April 2012, in
The percentage of patients aged 75 or over with a fragility fracture on or after 1 April 2012, who are currently treated with an appropriate...
The percentage of patients with a new diagnosis of hypertension in the preceding 12 months who have been screened for hazardous drinking using the...
The percentage of people aged 29 years and under, with a total cholesterol concentration greater than 7.5 mmol/l that are assessed against the Simon...
The percentage of people aged 30 years and older with a total cholesterol concentration greater than 9.0mmol/l that are assessed against the Simon...
The percentage of patients with moderate or severe frailty and/or multimorbidity who have received a medication review in the last 12 months which is...
The percentage of patients (aged 65 years and over) with moderate or severe frailty who have been asked whether they have had a fall, about the total...
The percentage of patients aged 80 years or over with coronary heart disease in whom the last blood pressure reading (measured in the preceding 12...
The percentage of patients aged 80 years or over with peripheral arterial disease in whom the last blood pressure reading (measured in the preceding...
The percentage of patients with heart failure on the register, who had a review in the preceding 12 months, including an assessment of functional...
The practice can produce a register of people with moderate to severe frailty. Subject(s): Multiple long-term conditions
The practice can produce a register of people with multimorbidity who would benefit from a tailored approach to care. Subject(s):
The percentage of adults and young people newly registered with a GP in an area of high or extremely high HIV prevalence who receive an HIV test...
The percentage of patients with dementia (diagnosed on or after 1 April 2014) with a record of FBC, calcium, glucose, renal and liver function,...
The percentage of patients with a new diagnosis of depression or anxiety in the preceding 12 months who have been screened for hazardous drinking...
NM168
NM166
The percentage of patients with coronary heart disease, stroke or transient ischemic attack, diabetes and/or chronic obstructive pulmonary disease who
The percentage of patients with diabetes, on the register, in whom the last IFCC-HbA1c is 75 mmol/mol or less in the preceding 12 months
The percentage of patients with diabetes, on the register, who have a record of retinal screening in the preceding 12 months Subject(s):
The percentage of patients with diabetes with a record of testing of foot sensation using a 10g monofilament within the preceding 12 months
The percentage of patients with hypertension or diabetes and a BMI of 27.5 kg/m2 or more (or 30 kg/m2 or more if ethnicity is recorded as White) in...
The percentage of patients with cancer, diagnosed within the preceding 24 months, who have a patient Cancer Care Review using a structured template...
Proportion of young people aged 12-18 years with diabetes who have had their urinary albumin recorded in the previous 12 months Subject(s):
NICE indicators. NM03 schizophrenia guidance.
NICE indicators. NM78 epilepsy guidance.
Percentage of patients on the learning disability register with Down's Syndrome aged 18 and over who have a record of blood TSH in the previous 15...
The percentage of patients with a new diagnosis of dementia recorded in the preceding 1 April to 31 March with a record of FBC, calcium, glucose,...
NICE indicators. NM11 depression guidance.
NICE indicators. NM10 depression guidance.